# Curis to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on November 12, 2026

- Source: PR Newswire M&A
- Published: 2026-11-05T21:38:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/curis-to-report-third-quarter-2026-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-12-2026-302931358.html
- Canonical: https://groundlevelnews.com/story/curis-to-report-third-quarter-2026-financial-and-operating-results-and-c9c2ea/

LEXINGTON, Mass., Nov. 5, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today announced that the Company will report its third quarter 2026...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._